TABLE 2.
Treatment-related adverse events.
| n (%) | Grade 1/2 | Grade 3 |
|---|---|---|
| *Injection site reaction | 14 (45%) | |
| Fatigue | 7 (23%) | |
| Nausea | 5 (16%) | |
| Diarrhoea | 3 (10%) | |
| Lymphocytopenia | 3 (10%) | |
| ALP elevation | 1 (3%) | 1 (3%) |
| Anaemia | 2 (6%) | |
| Anorexia | 2 (6%) | |
| Weight loss | 2 (6%) |
Adverse events reported as related to study medications in more than one patient.
No grade 4 events were observed.
ALP, alkaline phosphatase.
*Injection site reaction includes erythema, oedema, pruritis and discharge.